Amundi
AZN icon

Amundi’s AstraZeneca AZN Stock Holding History

Amundi’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03B Buy
15,386,149
+15,380,904
+293,249% +$2.97B 0.83% 14
2025
Q4 		$964K Buy
5,245
+63
+1% +$11K ﹤0.01% 1277
2025
Q3 		$886K Buy
5,182
+45
+0.9% +$6.81K ﹤0.01% 1184
2025
Q2 		$731K Buy
5,137
+1,809
+54% +$254K ﹤0.01% 1267
2025
Q1 		$492K Sell
3,328
-12,818
-79% -$1.85M ﹤0.01% 1492
2024
Q4 		$2.15M Sell
16,146
-7,890
-33% -$1.1M ﹤0.01% 1172
2024
Q3 		$3.7M Buy
24,036
+1,608
+7% +$260K ﹤0.01% 1039
2024
Q2 		$3.44M Sell
22,428
-28,958
-56% -$4.36M ﹤0.01% 1017
2024
Q1 		$7.03M Buy
51,386
+12,538
+32% +$1.66M ﹤0.01% 901
2023
Q4 		$5.35M Buy
38,848
+37,335
+2,468% +$4.85M ﹤0.01% 968
2023
Q3 		$204K Sell
1,513
-176,524
-99% -$24.1M ﹤0.01% 1593
2023
Q2 		$23.2M Buy
178,037
+16,931
+11% +$2.49M 0.01% 667
2023
Q1 		$23.2M Buy
161,106
+688
+0.4% +$92.6K 0.01% 677
2022
Q4 		$22.6M Sell
160,418
-2,394
-1% -$300K 0.01% 674
2022
Q3 		$18.5M Sell
162,812
-44,639
-22% -$5.66M 0.01% 710
2022
Q2 		$27M Sell
207,451
-10,156
-5% -$1.33M 0.02% 561
2022
Q1 		$30.9M Buy
217,607
+13,911
+7% +$1.67M 0.02% 569
2021
Q4 		$23.7M Sell
203,696
-130,531
-39% -$15.4M 0.02% 645
2021
Q3 		$40.1M Sell
334,227
-72,433
-18% -$8.43M 0.03% 511
2021
Q2 		$48.7M Buy
+406,660
New +$44.6M 0.03% 449

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Amundi's AZN Position: Q1 2026 in Review

Amundi increased its AstraZeneca (AZN) stake by 293,249% in Q1 2026, buying an estimated $2.97B and bringing the position to 15,386,149 shares worth $3.03B. The position accounts for 0.83% of the portfolio, ranked #14.

Amundi first reported a position in AZN in Q2 2021 and has held it in 20 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Amundi held 15,386,149 shares of AstraZeneca worth $3.03B as of Q1 2026.
  • Amundi bought 15,380,904 AstraZeneca shares in Q1 2026, an estimated $2.97B.
  • AstraZeneca made up 0.83% of Amundi's portfolio in Q1 2026, its #14 holding.
  • Amundi first reported a position in AstraZeneca in Q2 2021 and has held it in 20 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.